 | • レポートコード：MRC2012A5482 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、リポソームドラッグデリバリーの世界市場を広く調査・分析し、今後の市場展望をまとめております。リポソームドラッグデリバリーの種類別市場規模（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他）、用途別市場規模（真菌感染症治療、癌・腫瘍治療、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Gilead Sciences、CSPC、Johnson & Johnson、Pacira、Ipsen (Onivyde)、Sun Pharmaceutical、Novartis、Sigma-Tau Group、Luye Pharma、Teva Pharmaceutical、Fudan-Zhangjiang、 ・地域別グローバル市場分析 2015年-2020年 ・リポソームドラッグデリバリーの北米市場（アメリカ、カナダ、メキシコ） ・リポソームドラッグデリバリーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・リポソームドラッグデリバリーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・リポソームドラッグデリバリーの南米市場（ブラジル、アルゼンチン） ・リポソームドラッグデリバリーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他 ・用途別分析：真菌感染症治療、癌・腫瘍治療、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Liposomes Drug Delivery market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Liposomes Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 12.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 5473.4 million by 2025, from USD 3447.6 million in 2019.
Market segmentation
Liposomes Drug Delivery market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liposomes Drug Delivery market has been segmented into
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
By Application, Liposomes Drug Delivery has been segmented into:
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liposomes Drug Delivery market presented in the report. This section sheds light on the sales growth of different regional and country-level Liposomes Drug Delivery markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liposomes Drug Delivery market.
The report offers in-depth assessment of the growth and other aspects of the Liposomes Drug Delivery market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Liposomes Drug Delivery Market Share Analysis
Liposomes Drug Delivery competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liposomes Drug Delivery sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liposomes Drug Delivery sales, revenue and market share for each player covered in this report.
The major players covered in Liposomes Drug Delivery are:
Gilead Sciences
CSPC
Johnson & Johnson
Pacira
Ipsen (Onivyde)
Sun Pharmaceutical
Novartis
Sigma-Tau Group
Luye Pharma
Teva Pharmaceutical
Fudan-Zhangjiang
Among other players domestic and global, Liposomes Drug Delivery market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liposomes Drug Delivery product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liposomes Drug Delivery, with price, sales, revenue and global market share of Liposomes Drug Delivery in 2018 and 2019.
Chapter 3, the Liposomes Drug Delivery competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liposomes Drug Delivery breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Liposomes Drug Delivery market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Liposomes Drug Delivery sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Liposomes Drug Delivery Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liposomes Drug Delivery Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Liposomes Drug Delivery Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Overview of Global Liposomes Drug Delivery Market
1.4.1 Global Liposomes Drug Delivery Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences SWOT Analysis
2.1.4 Gilead Sciences Product and Services
2.1.5 Gilead Sciences Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CSPC
2.2.1 CSPC Details
2.2.2 CSPC Major Business
2.2.3 CSPC SWOT Analysis
2.2.4 CSPC Product and Services
2.2.5 CSPC Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pacira
2.4.1 Pacira Details
2.4.2 Pacira Major Business
2.4.3 Pacira SWOT Analysis
2.4.4 Pacira Product and Services
2.4.5 Pacira Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ipsen (Onivyde)
2.5.1 Ipsen (Onivyde) Details
2.5.2 Ipsen (Onivyde) Major Business
2.5.3 Ipsen (Onivyde) SWOT Analysis
2.5.4 Ipsen (Onivyde) Product and Services
2.5.5 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sun Pharmaceutical
2.6.1 Sun Pharmaceutical Details
2.6.2 Sun Pharmaceutical Major Business
2.6.3 Sun Pharmaceutical Product and Services
2.6.4 Sun Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Product and Services
2.7.4 Novartis Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sigma-Tau Group
2.8.1 Sigma-Tau Group Details
2.8.2 Sigma-Tau Group Major Business
2.8.3 Sigma-Tau Group Product and Services
2.8.4 Sigma-Tau Group Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Luye Pharma
2.9.1 Luye Pharma Details
2.9.2 Luye Pharma Major Business
2.9.3 Luye Pharma Product and Services
2.9.4 Luye Pharma Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical
2.10.1 Teva Pharmaceutical Details
2.10.2 Teva Pharmaceutical Major Business
2.10.3 Teva Pharmaceutical Product and Services
2.10.4 Teva Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Fudan-Zhangjiang
2.11.1 Fudan-Zhangjiang Details
2.11.2 Fudan-Zhangjiang Major Business
2.11.3 Fudan-Zhangjiang Product and Services
2.11.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Liposomes Drug Delivery Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Liposomes Drug Delivery Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Liposomes Drug Delivery Manufacturer Market Share in 2019
3.3.2 Top 6 Liposomes Drug Delivery Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Liposomes Drug Delivery Sales, Revenue and Market Share by Regions
4.1.1 Global Liposomes Drug Delivery Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liposomes Drug Delivery Revenue and Market Share by Regions (2015-2020)
4.2 North America Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
4.3 Europe Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
4.5 South America Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Liposomes Drug Delivery Sales, Revenue and Market Share by Country
5.1.1 North America Liposomes Drug Delivery Sales and Market Share by Country (2015-2020)
5.1.2 North America Liposomes Drug Delivery Revenue and Market Share by Country (2015-2020)
5.2 United States Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
5.3 Canada Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
5.4 Mexico Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Liposomes Drug Delivery Sales, Revenue and Market Share by Country
6.1.1 Europe Liposomes Drug Delivery Sales and Market Share by Country (2015-2020)
6.1.2 Europe Liposomes Drug Delivery Revenue and Market Share by Country (2015-2020)
6.2 Germany Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
6.3 UK Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
6.4 France Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
6.5 Russia Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
6.6 Italy Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Liposomes Drug Delivery Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Liposomes Drug Delivery Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Liposomes Drug Delivery Revenue and Market Share by Regions (2015-2020)
7.2 China Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
7.3 Japan Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
7.4 Korea Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
7.5 India Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
7.7 Australia Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Liposomes Drug Delivery Sales, Revenue and Market Share by Country
8.1.1 South America Liposomes Drug Delivery Sales and Market Share by Country (2015-2020)
8.1.2 South America Liposomes Drug Delivery Revenue and Market Share by Country (2015-2020)
8.2 Brazil Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
8.3 Argentina Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Liposomes Drug Delivery Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Liposomes Drug Delivery Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Liposomes Drug Delivery Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
9.3 Turkey Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
9.4 Egypt Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
9.5 South Africa Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Liposomes Drug Delivery Sales and Market Share by Type (2015-2020)
10.2 Global Liposomes Drug Delivery Revenue and Market Share by Type (2015-2020)
10.3 Global Liposomes Drug Delivery Price by Type (2015-2020)
11 Global Liposomes Drug Delivery Market Segment by Application
11.1 Global Liposomes Drug Delivery Sales Market Share by Application (2015-2020)
11.2 Global Liposomes Drug Delivery Revenue Market Share by Application (2015-2020)
11.3 Global Liposomes Drug Delivery Price by Application (2015-2020)
12 Market Forecast
12.1 Global Liposomes Drug Delivery Sales, Revenue and Growth Rate (2021-2025)
12.2 Liposomes Drug Delivery Market Forecast by Regions (2021-2025)
12.2.1 North America Liposomes Drug Delivery Market Forecast (2021-2025)
12.2.2 Europe Liposomes Drug Delivery Market Forecast (2021-2025)
12.2.3 Asia-Pacific Liposomes Drug Delivery Market Forecast (2021-2025)
12.2.4 South America Liposomes Drug Delivery Market Forecast (2021-2025)
12.2.5 Middle East & Africa Liposomes Drug Delivery Market Forecast (2021-2025)
12.3 Liposomes Drug Delivery Market Forecast by Type (2021-2025)
12.3.1 Global Liposomes Drug Delivery Sales Forecast by Type (2021-2025)
12.3.2 Global Liposomes Drug Delivery Market Share Forecast by Type (2021-2025)
12.4 Liposomes Drug Delivery Market Forecast by Application (2021-2025)
12.4.1 Global Liposomes Drug Delivery Sales Forecast by Application (2021-2025)
12.4.2 Global Liposomes Drug Delivery Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Liposomes Drug Delivery Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liposomes Drug Delivery Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Liposomes Drug Delivery Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Sciences Liposomes Drug Delivery Major Business
Table 10. Gilead Sciences Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 11. Gilead Sciences SWOT Analysis
Table 12. Gilead Sciences Liposomes Drug Delivery Product and Services
Table 13. Gilead Sciences Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. CSPC Basic Information, Manufacturing Base and Competitors
Table 15. CSPC Liposomes Drug Delivery Major Business
Table 16. CSPC Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 17. CSPC SWOT Analysis
Table 18. CSPC Liposomes Drug Delivery Product and Services
Table 19. CSPC Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 21. Johnson & Johnson Liposomes Drug Delivery Major Business
Table 22. Johnson & Johnson Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 23. Johnson & Johnson SWOT Analysis
Table 24. Johnson & Johnson Liposomes Drug Delivery Product and Services
Table 25. Johnson & Johnson Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pacira Basic Information, Manufacturing Base and Competitors
Table 27. Pacira Liposomes Drug Delivery Major Business
Table 28. Pacira Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 29. Pacira SWOT Analysis
Table 30. Pacira Liposomes Drug Delivery Product and Services
Table 31. Pacira Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Ipsen (Onivyde) Basic Information, Manufacturing Base and Competitors
Table 33. Ipsen (Onivyde) Liposomes Drug Delivery Major Business
Table 34. Ipsen (Onivyde) Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 35. Ipsen (Onivyde) SWOT Analysis
Table 36. Ipsen (Onivyde) Liposomes Drug Delivery Product and Services
Table 37. Ipsen (Onivyde) Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sun Pharmaceutical Liposomes Drug Delivery Major Business
Table 40. Sun Pharmaceutical Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 41. Sun Pharmaceutical SWOT Analysis
Table 42. Sun Pharmaceutical Liposomes Drug Delivery Product and Services
Table 43. Sun Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Novartis Basic Information, Manufacturing Base and Competitors
Table 45. Novartis Liposomes Drug Delivery Major Business
Table 46. Novartis Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 47. Novartis SWOT Analysis
Table 48. Novartis Liposomes Drug Delivery Product and Services
Table 49. Novartis Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Sigma-Tau Group Basic Information, Manufacturing Base and Competitors
Table 51. Sigma-Tau Group Liposomes Drug Delivery Major Business
Table 52. Sigma-Tau Group Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 53. Sigma-Tau Group SWOT Analysis
Table 54. Sigma-Tau Group Liposomes Drug Delivery Product and Services
Table 55. Sigma-Tau Group Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Luye Pharma Basic Information, Manufacturing Base and Competitors
Table 57. Luye Pharma Liposomes Drug Delivery Major Business
Table 58. Luye Pharma Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 59. Luye Pharma SWOT Analysis
Table 60. Luye Pharma Liposomes Drug Delivery Product and Services
Table 61. Luye Pharma Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 63. Teva Pharmaceutical Liposomes Drug Delivery Major Business
Table 64. Teva Pharmaceutical Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 65. Teva Pharmaceutical SWOT Analysis
Table 66. Teva Pharmaceutical Liposomes Drug Delivery Product and Services
Table 67. Teva Pharmaceutical Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Fudan-Zhangjiang Basic Information, Manufacturing Base and Competitors
Table 69. Fudan-Zhangjiang Liposomes Drug Delivery Major Business
Table 70. Fudan-Zhangjiang Liposomes Drug Delivery Total Revenue (USD Million) (2018-2019)
Table 71. Fudan-Zhangjiang SWOT Analysis
Table 72. Fudan-Zhangjiang Liposomes Drug Delivery Product and Services
Table 73. Fudan-Zhangjiang Liposomes Drug Delivery Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Liposomes Drug Delivery Sales by Manufacturer (2018-2019) (K Vial)
Table 75. Global Liposomes Drug Delivery Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Liposomes Drug Delivery Sales by Regions (2015-2020) (K Vial)
Table 77. Global Liposomes Drug Delivery Sales Market Share by Regions (2015-2020)
Table 78. Global Liposomes Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Liposomes Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 80. North America Liposomes Drug Delivery Sales Market Share by Countries (2015-2020)
Table 81. North America Liposomes Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Liposomes Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 83. Europe Liposomes Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 84. Europe Liposomes Drug Delivery Sales Market Share by Countries (2015-2020)
Table 85. Europe Liposomes Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Liposomes Drug Delivery Sales by Regions (2015-2020) (K Vial)
Table 87. Asia-Pacific Liposomes Drug Delivery Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Liposomes Drug Delivery Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Liposomes Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 90. South America Liposomes Drug Delivery Sales Market Share by Countries (2015-2020)
Table 91. South America Liposomes Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Liposomes Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Liposomes Drug Delivery Sales by Countries (2015-2020) (K Vial)
Table 94. Middle East & Africa Liposomes Drug Delivery Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Liposomes Drug Delivery Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Liposomes Drug Delivery Revenue Market Share by Countries (2015-2020)
Table 97. Global Liposomes Drug Delivery Sales by Type (2015-2020) (K Vial)
Table 98. Global Liposomes Drug Delivery Sales Share by Type (2015-2020)
Table 99. Global Liposomes Drug Delivery Revenue by Type (2015-2020) (USD Million)
Table 100. Global Liposomes Drug Delivery Revenue Share by Type (2015-2020)
Table 101. Global Liposomes Drug Delivery Sales by Application (2015-2020) (K Vial)
Table 102. Global Liposomes Drug Delivery Sales Share by Application (2015-2020)
Table 103. Global Liposomes Drug Delivery Sales Forecast by Regions (2021-2025) (K Vial)
Table 104. Global Liposomes Drug Delivery Market Share Forecast by Regions (2021-2025)
Table 105. Global Liposomes Drug Delivery Sales Forecast by Type (2021-2025) (K Vial)
Table 106. Global Liposomes Drug Delivery Market Share Forecast by Type (2021-2025)
Table 107. Global Liposomes Drug Delivery Sales Forecast by Application (2021-2025)
Table 108. Global Liposomes Drug Delivery Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Liposomes Drug Delivery Picture
Figure 2. Global Sales Market Share of Liposomes Drug Delivery by Type in 2019
Figure 3. Liposomal Doxorubicin Picture
Figure 4. Liposomal Amphoteracin B Picture
Figure 5. Liposomal Paclitaxel Picture
Figure 6. Others Picture
Figure 7. Liposomes Drug Delivery Sales Market Share by Application in 2019
Figure 8. Fungal Infection Therapy Picture
Figure 9. Cancer & Tumor Therapy Picture
Figure 10. Others Picture
Figure 11. Global Liposomes Drug Delivery Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Liposomes Drug Delivery Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Liposomes Drug Delivery Sales Market Share by Manufacturer in 2019
Figure 32. Global Liposomes Drug Delivery Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Liposomes Drug Delivery Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Liposomes Drug Delivery Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 37. Global Liposomes Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Liposomes Drug Delivery Revenue Market Share by Regions (2015-2020)
Figure 39. Global Liposomes Drug Delivery Revenue Market Share by Regions in 2018
Figure 40. North America Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
Figure 41. Europe Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
Figure 43. South America Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Liposomes Drug Delivery Sales and Growth Rate (2015-2020)
Figure 45. North America Liposomes Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Liposomes Drug Delivery Sales Market Share by Countries (2015-2020)
Figure 47. North America Liposomes Drug Delivery Sales Market Share by Countries in 2018
Figure 48. North America Liposomes Drug Delivery Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Liposomes Drug Delivery Revenue Market Share by Countries in 2018
Figure 50. United States Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 51. Canada Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 52. Mexico Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 53. Europe Liposomes Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Liposomes Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Liposomes Drug Delivery Revenue Market Share by Countries in 2019
Figure 56. Germany Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 57. UK Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 58. France Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 59. Russia Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 60. Italy Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 61. Asia-Pacific Liposomes Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Liposomes Drug Delivery Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Liposomes Drug Delivery Revenue Market Share by Regions 2019
Figure 64. China Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 65. Japan Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 66. Korea Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 67. India Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 68. Southeast Asia Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 69. South America Liposomes Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Liposomes Drug Delivery Sales Market Share by Countries in 2019
Figure 71. South America Liposomes Drug Delivery Revenue Market Share by Countries in 2019
Figure 72. Brazil Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 73. Argentina Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 74. Middle East and Africa Liposomes Drug Delivery Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 79. Egypt Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 80. Turkey Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 81. South Africa Liposomes Drug Delivery Sales and Growth Rate (2015-2020) (K Vial)
Figure 82. Global Liposomes Drug Delivery Sales and Growth Rate (2021-2025) (K Vial)
Figure 83. Global Liposomes Drug Delivery Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Liposomes Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 85. Europe Sales Liposomes Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 86. Asia-Pacific Sales Liposomes Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 87. South America Sales Liposomes Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 88. Middle East & Africa Sales Liposomes Drug Delivery Market Forecast (2021-2025) (K Vial)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
部位特異的ドラッグデリバリーの世界市場（～2026年） The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action…- リポソームの世界市場（～2026年） Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. North America dominated…
- 糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Therapy and Drug Delivery Scope and …
- 次世代糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
- ナノテクノロジードラッグデリバリーの世界市場（～2026年） Nano-technology field has a potential to make significant impact on healthcare by delivering disease diagnosis, monitoring, implants, regenerative medicines and drug delivery, drug discovery for biomedicine. Since last few years, significant progress has been made in the field of nano-medicine (i.e.…